Company intelligence / Profile preview

Radius Pharmaceuticals

Boston / Waltham, Massachusetts, United Statesradiuspharm.com ↗
Ownership
Private
Employees
~201
Development stage
Other
01

Overview

Radius Health has successfully commercialized TYMLOS® (abaloparatide), a peptide analog of parathyroid hormone-related protein, approved by the FDA for osteoporosis treatment in postmenopausal women and men at high risk of fracture. The company also markets BINOSTO® (alendronate sodium) effervescent tablets for osteoporosis. Clinical results show TYMLOS increases bone density and reduces fracture risk, including patients unresponsive to other therapies[1][2][3].

Therapeutic areas
EndocrinologyWomen's Health
Modalities
Small moleculePeptide
Industry
Biotech
02

Partnerships

Pharmanovia – exclusive commercialization rights to abaloparatide in China & select Asia-Pacific territories[4]Theramex – global partnerships for registration/commercialization outside US/EU/Asia-Pacific regions [3]Teijin, Labatec, Pharmbio Korea Inc., Biosidus – regional partners supporting product registration/commercialization [3]

Beyond the preview

Go deeper on Radius Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radius Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call